全球专家对临床实践中过敏性鼻炎的诊断,分类和药物治疗的看法,使用修改的Delphi面板技术
Désirée Es Larenas-Linnemann1, José L Mayorga-Butrón2, Juan Maza-Solano3
1Center of Excellence in Asthma and Allergy, Hospital Médica Sur, Mexico City, Mexico.
The World Allergy Organization journal
|July 31, 2023
概括
与指南相比,全球专家发现过敏性鼻炎 (AR) 诊断和治疗的显著差异. 这突显了临床实践和建议之间的差距,表明需要更新的管理策略.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
背景情况:
- 过敏性鼻炎 (AR) 的管理表现出相当大的差异,尽管存在治疗指南.
- 现实世界的临床实践往往与已建立的AR管理协议有所不同.
研究的目的:
- 阐明全球专家对过敏性鼻炎现实管理的共识.
- 确定当前AR治疗指南与实际临床实践之间的差异.
主要方法:
- 一个由两部分修改的Delphi小组研究,涉及全球过敏性鼻炎专家.
- 通过在线问卷和研讨会讨论,收集有关AR诊断,分类和药物治疗的专家意见.
主要成果:
- 专家们一致同意将观察和测试结合起来来诊断AR,以及严重程度,呼吸道干扰和症状频率对分类的重要性.
- 在特定的分类工具上没有达成共识,但鼻内皮质类固醇疗法 (INCS) 在较少的监测中受到青,治疗通常在3个月内逐步减少.
- 在药物治疗偏好和考虑选项,如根据需要的INCS和手术等方面观察到显著差异.
结论:
- 过敏性鼻炎治疗指南和专家的日常实践之间存在着显著的差距.
- 临床实践和药物治疗的变化凸显了需要进一步研究和局部准则的适应.
- 实施计划对于弥合AR指南与现实世界管理之间的差距至关重要.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
346
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
346
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Drugs Used in Lower Respiratory Disorders: Overview
489
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
489
Drugs Used in Upper Respiratory Disorders: Overview
291
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
291
Allergic Drug Reactions
878
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
878


